atenolol has been researched along with Hypersensitivity in 1 studies
Atenolol: A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect.
atenolol : An ethanolamine compound having a (4-carbamoylmethylphenoxy)methyl group at the 1-position and an N-isopropyl substituent.
Hypersensitivity: Altered reactivity to an antigen, which can result in pathologic reactions upon subsequent exposure to that particular antigen.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nunes, IKDC | 1 |
| de Souza, ET | 1 |
| Martins, IRR | 1 |
| Barbosa, G | 1 |
| Moraes Junior, MO | 1 |
| Medeiros, MM | 1 |
| Silva, SWD | 1 |
| Balliano, TL | 1 |
| da Silva, BA | 1 |
| Silva, PMR | 1 |
| Carvalho, VF | 1 |
| Martins, MA | 1 |
| Lima, LM | 1 |
1 other study available for atenolol and Hypersensitivity
| Article | Year |
|---|---|
Discovery of sulfonyl hydrazone derivative as a new selective PDE4A and PDE4D inhibitor by lead-optimization approach on the prototype LASSBio-448: In vitro and in vivo preclinical studies.
Topics: Animals; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 4; Drug Design; Enzyme Inhibitors; H | 2020 |